Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

10.95
-0.3000-2.67%
Post-market: 10.950.00000.00%18:49 EDT
Volume:246.15K
Turnover:2.70M
Market Cap:547.51M
PE:-9.24
High:11.27
Open:11.27
Low:10.90
Close:11.25
Loading ...
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2025

Major Issues Report

Form 8-K - Current report
May 20, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Mar 07, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Sep 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 16, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]